BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26327189)

  • 1. DBS sampling in imatinib therapeutic drug monitoring: from method development to clinical application.
    Antunes MV; Raymundo S; Wagner SC; Mattevi VS; Vieira N; Leite R; Reginato F; Capra MZ; Fogliatto L; Linden R
    Bioanalysis; 2015; 7(16):2105-17. PubMed ID: 26327189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First report of imatinib measurement in hair: Method development and preliminary evaluation of the relation between hair and plasma concentrations with therapeutic response in chronic myeloid leukemia.
    Capron A; Antunes MV; Wagner SC; Mattevi VS; Vieira N; Leite R; Reginato F; Capra M; Fogliatto L; Wallemacq P; Linden R
    Clin Chim Acta; 2016 Jan; 453():42-7. PubMed ID: 26657979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of total and unbound imatinib and metabolite LC-MS/MS assay to understand individual responses in CML and GIST patients.
    Streit F; Binder L; Hafke A; Brandhorst G; Braulke F; Haase D; Armbrust T; Cameron S; Ramadori G; Oellerich M; Walson P
    Ther Drug Monit; 2011 Oct; 33(5):632-43. PubMed ID: 21912334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of dried blood spot (DBS) technology versus plasma analysis for the determination of MK-1775 by HILIC-MS/MS in support of clinical studies.
    Xu Y; Fang W; Zeng W; Leijen S; Woolf EJ
    Anal Bioanal Chem; 2012 Dec; 404(10):3037-48. PubMed ID: 23099526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a dried blood spot sampling method towards therapeutic monitoring of radotinib in the treatment of chronic myeloid leukaemia.
    Lee J; Jung SY; Choi MY; Park JS; Park SK; Lim SA; Cho KH; Oh SY; Ha J; Kim DW; Lee J
    J Clin Pharm Ther; 2020 Oct; 45(5):1006-1013. PubMed ID: 32022312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the HCV Protease Inhibitor Telaprevir in Plasma and Dried Blood Spot by Liquid Chromatography-Tandem Mass Spectrometry.
    Verweij-van Wissen CP; de Graaff-Teulen MJ; de Kanter CT; Aarnoutse RE; Burger DM
    Ther Drug Monit; 2015 Oct; 37(5):626-33. PubMed ID: 25627404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manual punch versus automated flow-through sample desorption for dried blood spot LC-MS/MS analysis of voriconazole.
    Martial LC; van den Hombergh E; Tump C; Halmingh O; Burger DM; van Maarseveen EM; Brüggemann RJ; Aarnoutse RE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jul; 1089():16-23. PubMed ID: 29747155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simplified method for busulfan monitoring using dried blood spot in combination with liquid chromatography/tandem mass spectrometry.
    Ansari M; Uppugunduri CR; Déglon J; Théorêt Y; Versace F; Gumy-Pause F; Ozsahin H; Dayer P; Desmules J; Daali Y
    Rapid Commun Mass Spectrom; 2012 Jun; 26(12):1437-46. PubMed ID: 22592987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of dried blood spots as an alternative sampling strategy for 5-fluorouracil monitoring: From method development to clinical application.
    da Silva LC; Grando AP; de Baco LS; Hahn RZ; Ferreira Filho AF; Brucker N; Linden R; Antunes MV
    J Pharm Biomed Anal; 2023 Oct; 235():115539. PubMed ID: 37517245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A LC-MS/MS method for therapeutic drug monitoring of carbamazepine, lamotrigine and valproic acid in DBS.
    Linder C; Andersson M; Wide K; Beck O; Pohanka A
    Bioanalysis; 2015; 7(16):2031-9. PubMed ID: 26327183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DBS-LC-MS/MS assay for caffeine: validation and neonatal application.
    Bruschettini M; Barco S; Romantsik O; Risso F; Gennai I; Chinea B; Ramenghi LA; Tripodi G; Cangemi G
    Bioanalysis; 2016 Sep; 8(18):1893-902. PubMed ID: 27532249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of an analytical method using UPLC-MS/MS to quantify everolimus in dried blood spots in the oncology setting.
    Knapen LM; Beer Y; Brüggemann RJM; Stolk LM; Vries F; Tjan-Heijnen VCG; Erp NPV; Croes S
    J Pharm Biomed Anal; 2018 Feb; 149():106-113. PubMed ID: 29112898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of LC-MS/MS method for imatinib and norimatinib monitoring by finger-prick DBS in gastrointestinal stromal tumor patients.
    Iacuzzi V; Posocco B; Zanchetta M; Montico M; Marangon E; Poetto AS; Buzzo M; Gagno S; Buonadonna A; Guardascione M; Casetta B; Toffoli G
    PLoS One; 2019; 14(11):e0225225. PubMed ID: 31743371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Center punch" and "whole spot" bioanalysis of apixaban in human dried blood spot samples by UHPLC-MS/MS.
    Zheng N; Yuan L; Ji QC; Mangus H; Song Y; Frost C; Zeng J; Aubry AF; Arnold ME
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Apr; 988():66-74. PubMed ID: 25746754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of venlafaxine and O-desmethylvenlafaxine in dried blood spots for TDM purposes, using LC-MS/MS.
    Berm EJ; Brummel-Mulder E; Paardekooper J; Hak E; Wilffert B; Maring JG
    Anal Bioanal Chem; 2014 Apr; 406(9-10):2349-53. PubMed ID: 24493333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Validation of a Dried Blood Spot Assay for 8 Antihypertensive Drugs and 4 Active Metabolites.
    Peeters LEJ; Feyz L; Hameli E; Zwart T; Bahmany S; Daemen J; van Gelder T; Versmissen J; Koch BCP
    Ther Drug Monit; 2020 Jun; 42(3):460-467. PubMed ID: 31593031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation and Application of a Dried Blood Spot Assay for Biofilm-Active Antibiotics Commonly Used for Treatment of Prosthetic Implant Infections.
    Knippenberg B; Page-Sharp M; Salman S; Clark B; Dyer J; Batty KT; Davis TM; Manning L
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4940-55. PubMed ID: 27270283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of imatinib targeted delivery in human leukocytes.
    Kralj E; Žakelj S; Trontelj J; Pajič T; Preložnik Zupan I; Černelč P; Ostanek B; Marc J; Kristl A
    Eur J Pharm Sci; 2013 Sep; 50(1):123-9. PubMed ID: 23643738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women Administered Standard Dose Imatinib for Chronic Myeloid Leukemia Have Higher Dose-Adjusted Plasma Imatinib and Norimatinib Concentrations Than Men.
    Belsey SL; Ireland R; Lang K; Kizilors A; Ho A; Mufti GJ; Bisquera A; De Lavallade H; Flanagan RJ
    Ther Drug Monit; 2017 Oct; 39(5):499-504. PubMed ID: 28767619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous determination of fluoxetine and norfluoxetine in dried blood spots using high-performance liquid chromatography-tandem mass spectrometry.
    da Silva ACC; Raasch JR; Vargas TG; Peteffi GP; Hahn RZ; Antunes MV; Perassolo MS; Linden R
    Clin Biochem; 2018 Feb; 52():85-93. PubMed ID: 28987790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.